Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...
After an agency review, the FDA asked drugmakers to remove warnings about a potential risk of suicidal thoughts from widely ...
Friendly" labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...
Agency officials say a comprehensive review “found no increased risk” related to suicide among users of the GLP-1 drugs used ...
A more detailed review of data by the FDA showed that GLP-1 drugs do not increase the risk of suicidal ideation or behavior.
The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out ...
So I wasn’t surprised when Williams was hit with a whole lot of “how dare you”—as Oprah Winfrey put it on the January 13 ...
Federal regulators on Tuesday told drugmakers Novo Nordisk and Eli Lilly to remove label warnings about potential suicidal ...
The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...
There’s no sign of GLP-1s slowing down anytime soon, especially now that they have the support of top-notch athletes.
The new drugs could become the way forward for medicated weight loss as clinical trials reveal optimistic results ...
Oprah Winfrey says she had one big main side effect from taking a GLP-1 weight-loss drug. The most common problems for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results